Qinghai Spring Medicinal Resources Technology Co 600381.SS · CNY
Health Care · Shanghai · 🇨🇳 China
4.18
+3.98%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Qinghai Spring Medicinal Resources Technology Co
Its shares trade on Shanghai under the ticker 600381.SS. It has been listed since 8 May 2001. In the fiscal year to 31 December 2025, it reported revenue of CN¥343.4m and a net loss of CN¥37.3m. At that date it held total assets of CN¥1.04bn and shareholders' equity of CN¥995.2m.
Qinghai Spring Medicinal Resources Technology Co., Ltd. is engaged in the coal, steel and real estate industry. The company is headquartered in Xining, Qinghai. The company went IPO on 2001-05-08. The Company’s main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company’s subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 8 May 2001
- Employees
- 175
- Website
- verygrass.com ↗
Leadership
Pay as last reported
- Mr. Xuefeng ZhangChairman of the Board, General Manager, since 2017
- Ms. Lin WangChief Financial Officer
- Mr. Ding ChenDeputy General Manager, Secretary of the Board, Director, since 2023
- Mr. Tiepeng YaoDeputy General Manager, Director
- Ms. Lingxiao LiuDeputy General Manager
- Ms. Rong XiaoDirector
- Mr. Bojun DongIndependent Director
- Mr. Xuemin GaoIndependent Director
- Ms. Yuqi SongIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Qinghai Spring Medicinal Resources Technology Co Ltd focuses on cordyceps sinensis products under Verygrass brand.
- The company's subsidiary Qinghai Spring Pharmaceutical Resource Utilization Co Ltd supports its pharmaceutical operations.
- Qinghai Spring employs 175 full-time employees in the Health Care sector.
Weaknesses
- The company operates in the coal, steel, and real estate industries alongside Pharmaceuticals.
- Qinghai Spring's business description incorrectly lists coal and steel as primary industries.
- The company's main products are limited to cordyceps sinensis series under Verygrass brand.
Opportunities
- Qinghai Spring can expand its cordyceps sinensis products into the Chinese market.
- The Health Care sector offers growth opportunities for pharmaceutical companies like Qinghai Spring.
- Qinghai Spring's subsidiary Qinghai Spring Pharmaceutical Resource Utilization Co Ltd can drive innovation.
Threats
- The company's incorrect industry listing may confuse investors and stakeholders.
- Qinghai Spring faces competition from other pharmaceutical companies in the Health Care sector.
- The company's focus on cordyceps sinensis products could limit market diversification.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.